Consulting and implementation

Regulatory consulting and localization implementation

Use the public library as a reference layer, then bring us the real project context: company, product, current approvals, and target countries. We help turn country rules into a practical registration and local landing plan.

What we can help with

The service is built around the decisions that usually block overseas registration: pathway, evidence, local responsibility, dossier conversion, timing, and post-market control.

Regulatory pathway assessment

Clarify classification, filing route, regulator, local representative, expected evidence, timing, and cost drivers by target country.

FDA, CE, MDSAP, and NMPA leverage

Assess whether existing approvals or quality-system evidence can support reliance, abridged review, dossier reuse, or QMS audit reduction.

Localization landing plan

Map local holder, importer, distributor, labeling, language, registration ownership, and post-market responsibility before partner signing.

Dossier gap review

Compare current technical files, test reports, clinical evidence, certificates, and QMS documents against the target-market submission package.

Multi-country sequencing

Decide which markets should come first based on evidence readiness, reference-approval value, local burden, and commercial timing.

Labeling and language readiness

Plan local-language labeling, IFU, distributor information, claims control, and country-specific document conversion.

From reference research to local execution

A country page can explain the rule pattern. A project still needs product classification, certificate leverage, local holder design, label and language work, document conversion, and local partner coordination.

01

Collect company, product, risk class, intended use, existing approvals, and target-country list.

02

Compare target-market pathways and identify where FDA, CE, MDSAP, or NMPA evidence may help.

03

Build a local execution map: holder model, dossier conversion, labeling, partner role, timeline, and risk controls.

04

Prioritize the first filing wave and define what must be verified with local professionals before submission.

Who should use this library

The library is most useful for teams that need a reliable first view before investing in filing, market-entry sequencing, or local partner selection.

Manufacturers and export teams

Teams preparing to sell medical devices outside their home market and needing an early registration path comparison.

RA, QA, and compliance leaders

Teams checking classification, dossier gaps, certificate reuse, QMS evidence, and post-market obligations.

BD and international sales teams

Teams comparing countries before choosing distributors, signing local partners, or committing commercial launch dates.

Distributors and local partners

Partners who need to understand local holder duties, import roles, registration ownership, and execution boundaries.

Investors and acquisition teams

Teams evaluating whether a product line, certificate portfolio, or target company can support multi-country expansion.

Send project details

Tell us your company, product, and target countries

This website is a reference for enterprise planning. For deeper project discussion, leave company information, product information, and target countries. We will contact you for the next step.

Project consultation

Leave your company, product, current approvals, and target countries. We will follow up with the right regulatory and localization questions.